CMS final rule seeks to unleash medical innovation, revise payment for FDA Breakthrough Devices designation

“The Centers for Medicare and Medicaid Services has finalized a rule to promote quicker access to new medical technology through changes in payment policies…”

“The Inpatient Prospective Payment System (IPPS) and the Long-Term Care Hospital Prospective Payment System for Fiscal Year 2020 increases Medicare add-on payments—called new technology add-on payments (NTAP)—for cases with high costs involving eligible new technologies, with payment increasing from 50 percent to 65 percent.”

“In addition, CMS is revising payment policies for medical devices that meet the Food and Drug Administration’s Breakthrough Devices designation for expedited FDA approval or clearance.”

“The FDA’s Breakthrough Devices Program—first authorized in late 2016—is intended to offer new ways to treat or diagnose a disease or condition, have significant advantages over existing treatment or diagnostic alternatives or provide another public health benefit.” Read the full article here.

Source: CMS final rule seeks to unleash medical innovation – By Greg Slabodkin, August 5, 2019. Health Data Management.

Related Post


LEAVE A REPLY

Please enter your comment!
Please enter your name here